HSBC Holdings’s PDL BioPharma, Inc. PDLI Stock Holding History

HSBC Holdings’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-93,256	Closed	-$296K	–	3207
2020 Q3	$296K	Sell	93,256 -5,378	-5%	-$17.2K	﹤0.01%	2267
2020 Q2	$287K	Buy	+98,634	New	+$312K	﹤0.01%	2156
2020 Q1	–	Sell	-13,072	Closed	-$43K	–	3183
2019 Q4	$43K	Buy	13,072 +616	+5%	+$1.79K	﹤0.01%	2978
2019 Q3	$27K	Buy	+12,456	New	+$33.3K	﹤0.01%	3034
2019 Q2	–	Sell	-10,175	Closed	-$38K	–	2954
2019 Q1	$38K	Buy	+10,175	New	+$34.4K	﹤0.01%	2660
2017 Q2	–	Sell	-223,634	Closed	-$520K	–	2364
2017 Q1	$520K	Sell	223,634 -27,057	-11%	-$59.9K	﹤0.01%	1597
2016 Q4	$531K	Buy	250,691 +27,860	+13%	+$77.7K	﹤0.01%	1784
2016 Q3	$745K	Hold	222,831	–	–	﹤0.01%	1435
2016 Q2	$700K	Buy	222,831 +1,716	+0.8%	+$5.72K	﹤0.01%	1451
2016 Q1	$737K	Buy	221,115 +553	+0.3%	+$1.72K	﹤0.01%	1414
2015 Q4	$786K	Sell	220,562 -4,016	-2%	-$16.8K	﹤0.01%	1529
2015 Q3	$1.13M	Sell	224,578 -168,154	-43%	-$964K	﹤0.01%	1192
2015 Q2	$2.54M	Buy	392,732 +99,956	+34%	+$670K	0.01%	1011
2015 Q1	$2.06M	Buy	+292,776	New	+$2.12M	﹤0.01%	1171

Other funds holding PDLI

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return

JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Hancock Whitney Gulfport, Mississippi $6B AUM 34.57% 1-Year Est. Return

HSBC Holdings's PDLI Position: Q4 2020 in Review

HSBC Holdings sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 93,256 shares — an estimated $296K sold.

HSBC Holdings first reported a position in PDLI in Q1 2015 and held it in 14 quarters. The position peaked at $2.54M in Q2 2015. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

HSBC Holdings reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
HSBC Holdings sold 93,256 PDL BioPharma, Inc. shares in Q4 2020, an estimated $296K.
HSBC Holdings first reported a position in PDL BioPharma, Inc. in Q1 2015 and held it in 14 quarters.
HSBC Holdings's PDL BioPharma, Inc. position peaked at $2.54M in Q2 2015.
33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on HSBC Holdings's 13F filing for Q4 2020, filed 12 Feb 2021.